Enteric-coated HT-2157 compositions and methods of their use
US8277842B1 · kind B1 · utility
1Cited by
1References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 20, 2012 |
| Grant date | Oct 2, 2012 |
| Priority date | — |
| Expiry date | Jan 20, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Drug compositions comprising the compound HT-2157 and their therapeutic uses, including the treatment of CNS disorders and cognitive impairments and the modulation of cognitive function, are disclosed. More particularly, the present invention relates to enteric-coated formulations comprising HT-2157 that reduce the appearance of clinically relevant methemoglobinemia relative to administration of non-enteric-coated formulations comprising HT-2157.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.